PL2859891T5 - Zastosowanie kompozycji do zapobiegania zapaleniu błony śluzowej powodowanego radio- lub chemioterapią - Google Patents

Zastosowanie kompozycji do zapobiegania zapaleniu błony śluzowej powodowanego radio- lub chemioterapią

Info

Publication number
PL2859891T5
PL2859891T5 PL14187915T PL14187915T PL2859891T5 PL 2859891 T5 PL2859891 T5 PL 2859891T5 PL 14187915 T PL14187915 T PL 14187915T PL 14187915 T PL14187915 T PL 14187915T PL 2859891 T5 PL2859891 T5 PL 2859891T5
Authority
PL
Poland
Prior art keywords
chemotherapy
prevention
radiation
combination
induced mucositis
Prior art date
Application number
PL14187915T
Other languages
English (en)
Other versions
PL2859891T3 (pl
Inventor
Paolo Giorgetti
Original Assignee
Professional Dietetics International S.r.l. in forma abbreviata P.D. INT. S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49585533&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2859891(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Professional Dietetics International S.r.l. in forma abbreviata P.D. INT. S.R.L. filed Critical Professional Dietetics International S.r.l. in forma abbreviata P.D. INT. S.R.L.
Publication of PL2859891T3 publication Critical patent/PL2859891T3/pl
Publication of PL2859891T5 publication Critical patent/PL2859891T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
PL14187915T 2013-10-08 2014-10-07 Zastosowanie kompozycji do zapobiegania zapaleniu błony śluzowej powodowanego radio- lub chemioterapią PL2859891T5 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001660A ITMI20131660A1 (it) 2013-10-08 2013-10-08 Uso di una combinazione per la prevenzione delle mucositi indotte da radiazioni o da chemioterapici
EP14187915.5A EP2859891B2 (en) 2013-10-08 2014-10-07 Use of a combination for the prevention of radiation- or chemotherapy-induced mucositis

Publications (2)

Publication Number Publication Date
PL2859891T3 PL2859891T3 (pl) 2018-11-30
PL2859891T5 true PL2859891T5 (pl) 2022-02-07

Family

ID=49585533

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14187915T PL2859891T5 (pl) 2013-10-08 2014-10-07 Zastosowanie kompozycji do zapobiegania zapaleniu błony śluzowej powodowanego radio- lub chemioterapią

Country Status (8)

Country Link
EP (1) EP2859891B2 (pl)
DK (1) DK2859891T4 (pl)
ES (1) ES2669121T5 (pl)
IT (1) ITMI20131660A1 (pl)
NO (1) NO2859891T3 (pl)
PL (1) PL2859891T5 (pl)
PT (1) PT2859891T (pl)
TR (1) TR201807022T4 (pl)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050256042A1 (en) 2003-05-09 2005-11-17 Jeffers Michael E Methods of preventing and treating alimentary mucositis
CN100448453C (zh) 2003-05-22 2009-01-07 努特里奇亚有限公司 治疗或预防慢性创伤的方法及其中所使用的包含甘氨酸和/或亮氨酸的全营养组合物
ITMI20052035A1 (it) 2005-10-26 2007-04-27 Professional Dietetics Srl Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato
IT1396935B1 (it) * 2009-11-26 2012-12-20 Solartium Entpr Ltd Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici

Also Published As

Publication number Publication date
ES2669121T5 (es) 2022-03-29
EP2859891B1 (en) 2018-02-21
ITMI20131660A1 (it) 2015-04-09
DK2859891T3 (en) 2018-04-23
EP2859891B2 (en) 2021-10-06
TR201807022T4 (tr) 2018-06-21
ES2669121T3 (es) 2018-05-24
PT2859891T (pt) 2018-05-17
DK2859891T4 (da) 2022-01-10
EP2859891A1 (en) 2015-04-15
NO2859891T3 (pl) 2018-07-21
PL2859891T3 (pl) 2018-11-30

Similar Documents

Publication Publication Date Title
HRP20180684T1 (hr) Kombinacija lijekova
DK2910395T3 (da) Planetgear med integreret driftsbremse
IL243572A0 (en) Drug combination for the treatment of melanoma
GB201308131D0 (en) Ophthalmoscope
AU351404S (en) A collimator
HK1214330A1 (zh) 次性使用的閥
GB201302863D0 (en) The Instaponytail
GB201322406D0 (en) Deactivating tappet
IL244528A0 (en) Lip balm complex
GB201306901D0 (en) Combination
PL2859891T5 (pl) Zastosowanie kompozycji do zapobiegania zapaleniu błony śluzowej powodowanego radio- lub chemioterapią
GB201413253D0 (en) Solid dosage form
GB201306554D0 (en) Chain wear gauge
AU4880P (en) Comet Avena sativa
GB201316662D0 (en) Pharmaceutical Combination
GB201320647D0 (en) Immunoconjugates
GB201318043D0 (en) Immunoconjugates
GB201307599D0 (en) Immunoconjugates
TWM475271U (en) Sanitary pad
GB201320786D0 (en) Medicament
EP2994603A4 (en) CHAIN SERVICE INDICATOR
GB201313319D0 (en) Anti Splash Ring
GB201302007D0 (en) Sanitary pad wrapper
GB201316431D0 (en) Dental Phantom
GB201307715D0 (en) Crushable fluid